DSM (diagnostic and statistic manual of mental disorders)
DSM I 1952
DSM II 1968
DSM III 1980
DSM IV 1994
Major change was clinical significance criteria: individual has to exhibit clinical impairment or significant distress in daily functioning to be diagnosed with a disorders
- done to reduce overmedicalisation
- gives an account of the broad range of information about the patient’s mental state through Medical Screening Examination
- 5 dimensions
5 dimensions
1) Clinical disorders - patterns of behavior that impair function
2) Personality disorders - rigid patterns of maladaptive behavior that become a part of the person’s personality
3) General medical conditions
4) Psychosocial and environmental porblems
5) Global assessment of functioning
DSM V 2013
key criticisms of DSM V
Chinese classification of mental disorders (1979)
key criticism of CCMD
kleinman (1982)
aim - to investigate if neurasthania in China would be similar to depression is DSM-III
Method: Kleinman interviewed 100 patients diagnosed with neurasthania using structured interviews based off of DSM III diagnostic criteria
Results - 80% could be classified as having depression; 90% complained of headaches, 78% of insomnia, 73% of dizziness, 48% of various pains. Depressed mood was only a complaint in 9% of cases.
Evaluation - neurasthania could be Chinese way of expressing depression in somatic ways as patients majorly had physical symptoms
- difficult to compare to Western data because patients don’t make the same complaints, shows a concern of cross-cultural diagnosis. Somatization may be cultural mode of stress in China, while in West common mode of stress is psychologization
Strength - CCMD increases cultural validity by including terms like neurasthania, cultural context prevents stigmatization and labels in relation to DSM
Weakness - Lack of cross cultural validity as the disorder is classified differently in DSM